Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Juan Li, Lei Zheng, Rongmei Wang, Deqing Sun, Shuang Liang, Jing Wu, Yongqing Liu, Xiaona Tian, Tingting Li, Yang Yang & Leiqiang Han. (2020) Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance. International Journal of Nanomedicine 15, pages 5839-5853.
Read now
Read now
Lin-Feng You, Jia-Jun Huang, Shu-Ling Lin, Tao Wei, Qian-Wang Zheng, Bing-Hua Jiang, Jun-Fang Lin & Li-Qiong Guo. (2019) In vitro enzymatic synthesis of baccatin III with novel and cheap acetyl donors by the recombinant taxoid 10β-O-acetyl transferase. Biocatalysis and Biotransformation 37:4, pages 239-245.
Read now
Read now
Junpeng Nie, Wei Cheng, Yunmei Peng, Gan Liu, Yuhan Chen, Xusheng Wang, Chaoyu Liang, Wei Tao, Yinping Wei, Xiaowei Zeng & Lin Mei. (2017) Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects. Drug Delivery 24:1, pages 1124-1138.
Read now
Read now
Articles from other publishers (25)
Liu-Ru Fang, Yu-Hua Wang, Zu-Zhao Xiong & Yu-Mei Wang. (2023) Research progress of nanomaterials in tumor-targeted drug delivery and imaging therapy. OpenNano 14, pages 100184.
Crossref
Crossref
Kunj Vyas, Maharshsinh Rathod & Mayur M. Patel. (2023) Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer. Nanomedicine: Nanotechnology, Biology and Medicine 49, pages 102662.
Crossref
Crossref
Londiwe Simphiwe Mbatha, Jude Akinyelu, Chika Ifeanyi Chukwuma, Mduduzi Paul Mokoena & Tukayi Kudanga. (2023) Current Trends and Prospects for Application of Green Synthesized Metal Nanoparticles in Cancer and COVID-19 Therapies. Viruses 15:3, pages 741.
Crossref
Crossref
Beibei Zhao, Zhengbiao Gu, Yayuan Zhang, Zhaofeng Li, Li Cheng, Caiming Li & Yan Hong. (2022) Starch-based carriers of paclitaxel: A systematic review of carriers, interactions, and mechanisms. Carbohydrate Polymers 291, pages 119628.
Crossref
Crossref
Parisa Shamshiripour, Fahimeh Hajiahmadi, Shahla Lotfi, Niloofar Robab Esmaeili, Amir Zare, Mahzad Akbarpour & Davoud Ahmadvand. (2022) Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside. Frontiers in Immunology 13.
Crossref
Crossref
Shin-nosuke Nishimura, Kei Nishida & Masaru Tanaka. (2022) A β-hairpin peptide with pH-controlled affinity for tumor cells. Chemical Communications 58:4, pages 505-508.
Crossref
Crossref
Armin Tahmasbi Rad, Derek Hargrove, Leila Daneshmandi, Amanda Ramsdell, Xiuling Lu & Mu-Ping Nieh. (2021) Codelivery of Paclitaxel and Parthenolide in Discoidal Bicelles for a Synergistic Anticancer Effect: Structure Matters. Advanced NanoBiomed Research 2:1.
Crossref
Crossref
Mahendra Kumar Prajapati, Rohan Pai & Pradeep Vavia. (2021) Tuning ligand number to enhance selectivity of paclitaxel liposomes towards ovarian cancer. Journal of Drug Delivery Science and Technology 66, pages 102809.
Crossref
Crossref
Solmaz Mojarad-Jabali, Masoud Farshbaf, Paul R. Walker, Salar Hemmati, Yousef Fatahi, Parvin Zakeri-Milani, Muhammad Sarfraz & Hadi Valizadeh. (2021) An update on actively targeted liposomes in advanced drug delivery to glioma. International Journal of Pharmaceutics 602, pages 120645.
Crossref
Crossref
Vrinda Gote, Anantha Ram Nookala, Pradeep Kumar Bolla & Dhananjay Pal. (2021) Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. International Journal of Molecular Sciences 22:9, pages 4673.
Crossref
Crossref
Huaisong Wang, Lin Wang, Yueyuan Gao & Ya Ding. (2021) The effect of drug position on the properties of paclitaxel-conjugated gold nanoparticles for liver tumor treatment. Chinese Chemical Letters 32:3, pages 1041-1045.
Crossref
Crossref
Yan Wang, Mies J. van Steenbergen, Nataliia Beztsinna, Yang Shi, Twan Lammers, Cornelus F. van Nostrum & Wim E. Hennink. (2020) Biotin-decorated all-HPMA polymeric micelles for paclitaxel delivery. Journal of Controlled Release 328, pages 970-984.
Crossref
Crossref
Seyed Hossein Kiaie, Solmaz Mojarad-Jabali, Farnaz Khaleseh, Saeideh Allahyari, Elham Taheri, Parvin Zakeri-Milani & Hadi Valizadeh. (2020) Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives. International Journal of Pharmaceutics 581, pages 119269.
Crossref
Crossref
Aiyun Liu, Huaisong Wang, Xiaoshuang Hou, Yu Ma, Gongjun Yang, Yanglong Hou & Ya Ding. (2020) Combinatory antitumor therapy by cascade targeting of a single drug. Acta Pharmaceutica Sinica B 10:4, pages 667-679.
Crossref
Crossref
Aria W. Tarudji & Forrest M. Kievit. 2020. Nanoparticles for Biomedical Applications. Nanoparticles for Biomedical Applications
19
36
.
Mahendra Kumar Prajapati, Aniketh Bishnu, Pritha Ray & Pradeep R. Vavia. (2019) Selectivity Enhancement of Paclitaxel Liposome Towards Folate Receptor-Positive Tumor Cells by Ligand Number Optimization Approach. AAPS PharmSciTech 20:8.
Crossref
Crossref
Saras Jyoti & Simran Tandon. (2019) Disruption of mitochondrial membrane potential coupled with alterations in cardiac biomarker expression as early cardiotoxic signatures in human ES cell–derived cardiac cells. Human & Experimental Toxicology 38:9, pages 1111-1124.
Crossref
Crossref
Ghassem Rezaei, Seyed Mojtaba Daghighi, Ismael Haririan, Iman Yousefi, Mohammad Raoufi, Farhad Rezaee & Rassoul Dinarvand. (2019) Protein corona variation in nanoparticles revisited: A dynamic grouping strategy. Colloids and Surfaces B: Biointerfaces 179, pages 505-516.
Crossref
Crossref
Nan Jiang, Jing‑Jing Lin, Jun Wang, Bei‑Ning Zhang, Ao Li, Zheng‑Yang Chen, Song Guo, Bin‑Bin Li, Yu‑Zhong Duan, Ru‑Yi Yan, Hong‑Feng Yan, Xiao‑Yan Fu, Jin‑Lian Zhou, He‑Ming Yang & Yan Cui. (2018) Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review). Experimental and Therapeutic Medicine.
Crossref
Crossref
Qin Chen, Guangxuan Liu, Shuo Liu, Hongyan Su, Yue Wang, Jingyu Li & Cong Luo. (2018) Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics. Trends in Pharmacological Sciences 39:1, pages 59-74.
Crossref
Crossref
Ines Truebenbach, Jan Gorges, Jasmin Kuhn, Sarah Kern, Emanuele Baratti, Uli Kazmaier, Ernst Wagner & Ulrich Lächelt. (2017) Sequence‐Defined Oligoamide Drug Conjugates of Pretubulysin and Methotrexate for Folate Receptor Targeted Cancer Therapy. Macromolecular Bioscience 17:10.
Crossref
Crossref
Fiona Maiyo & Moganavelli Singh. (2017) Selenium nanoparticles: potential in cancer gene and drug delivery. Nanomedicine 12:9, pages 1075-1089.
Crossref
Crossref
Marcela A. Moretton, Ezequiel Bernabeu, Estefanía Grotz, Lorena Gonzalez, Marcela Zubillaga & Diego A. Chiappetta. (2017) A glucose-targeted mixed micellar formulation outperforms Genexol in breast cancer cells. European Journal of Pharmaceutics and Biopharmaceutics 114, pages 305-316.
Crossref
Crossref
Yuling Chen & Zilin Chen. (2017) COF-1-modified magnetic nanoparticles for highly selective and efficient solid-phase microextraction of paclitaxel. Talanta 165, pages 188-193.
Crossref
Crossref
Yuping Wei, Liang Zhang, Yankai Fu & Xia Xu. (2017) Rapid delivery of paclitaxel with an organic solvent-free system based on a novel cell penetrating peptide for suppression of tumor growth. Journal of Materials Chemistry B 5:37, pages 7768-7774.
Crossref
Crossref